Prasad Nimmagadda, Head of Global Strategies at MYLAN LABORATORIES INC (MYL), bought 1,199,039 shares at $20.85 ($25.0M) on 2007-02-15, disclosed to the SEC on 2007-02-16.
Open-market purchase of $25.0M MYL by Head of Global Strategies. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.